1. Home
  2. PCB vs KMDA Comparison

PCB vs KMDA Comparison

Compare PCB & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCB Bancorp

PCB

PCB Bancorp

N/A

Current Price

$21.49

Market Cap

325.6M

Sector

Finance

ML Signal

N/A

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.83

Market Cap

385.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCB
KMDA
Founded
2003
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
325.6M
385.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PCB
KMDA
Price
$21.49
$7.83
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$24.50
$13.00
AVG Volume (30 Days)
27.7K
95.1K
Earning Date
01-29-2026
11-10-2025
Dividend Yield
3.71%
2.69%
EPS Growth
43.50
30.41
EPS
2.41
0.35
Revenue
$107,743,000.00
$174,787,000.00
Revenue This Year
$21.55
$14.79
Revenue Next Year
$8.65
$10.74
P/E Ratio
$8.94
$20.91
Revenue Growth
13.61
10.36
52 Week Low
$16.00
$5.54
52 Week High
$24.04
$9.16

Technical Indicators

Market Signals
Indicator
PCB
KMDA
Relative Strength Index (RSI) 42.31 71.72
Support Level $21.27 $6.92
Resistance Level $22.24 $7.17
Average True Range (ATR) 0.55 0.17
MACD -0.18 0.05
Stochastic Oscillator 9.19 78.33

Price Performance

Historical Comparison
PCB
KMDA

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: